Cardiome Falls Most Since 1999 After Merck Ends Drug Testing

Cardiome Pharma Corp. dropped the most in about 13 years after Merck & Co. ended development of a pill form of Cardiome’s injected drug for irregular heartbeat.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.